Announcement: GLP-1 Drugs Like Ozempic Cut Heart Attack Risk by 20% in Major Review

Last updated: 02/06/2026 14:41

0 Min Read

Major international review finds GLP-1 drugs like Ozempic reduce heart attack risk by 20% and stroke risk by 18%. The cardiovascular benefits appear within 12-18 months regardless of diabetes status. — Photo: Haberdoedas Photography / Pexels

1 min read|38 words

🚨 BREAKING: Major review finds GLP-1 drugs like Ozempic reduce heart attack risk by 20% and stroke by 18%! Benefits appear within 12-18 months regardless of diabetes status. This could transform cardiovascular prevention worldwide.

Read the full article on GMJ Newsroom →

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: GLP-1 Drugs Like Ozempic Cut Heart Attack Risk by 20% in Major Review →

Share This Article